Studies overweight and obesity in adults with type 1 diabetes
Records adults with type 1 diabetes and obesity to study their treatment response.
Plain-language title generated from the registry record
Registry title: Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
Key facts
- Where
- Leuven, BelgiumSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 1 diabetes who visited the Department of Endocrinology of the University Hospitals of Leuven. It records how patients with type 1 diabetes and obesity respond to treatment.
- Sex
- All sexes can join.
- Disease stage
- Type 1 diabetes.
Read by machine on 12 November 2026.
Where in Belgium
- Departement Endocrinology, University Hospitals LeuvenLeuven, BelgiumContact: Bart Van der Schueren, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Universitaire Ziekenhuizen KU Leuven
- Trial code
- NCT05713448
- Record updated
- 1 July 2024
- Original description
A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomesRead full original descriptionShow less
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes and Its Effect on Treatment and Associated Co-morbidities
A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomes
Inclusion: Signed informed consent; Type 1 Diabetes.